汉字News

← 汉字News
Chinese News for Learners
commerce
shāng yè
商业
·HSK 4

Merck (US pharmaceutical company)
Mòkè
默克
to announce
xuānbù
宣布
at / for (price)
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals

Merck company
Mòkè gōngsī
默克公司
to announce
xuānbù
宣布
at / for (price)
approximately
yuē
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
to obtain / to acquire
huòqǔ
获取
its
leukemia
báixuèbìng
白血病
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
this / the current
cǐ cì
此次
merger and acquisition
bìnggòu
并购
aimed at
zhǐzài
旨在
to strengthen / to bolster
qiánghuà
强化
Merck
Mòkè
默克
structural particle
de
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
to address / to cope with
yǐ yìngduì
以应对
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
patent
zhuānlì
专利
expiry / to expire
dàoqī
到期
structural particle
de
pressure / challenge
yālì
压力

March 25, 2026 at 6:00 PM

the United States
Měiguó
美国
pharmaceutical
zhìyào
制药
giant / major player
jùtóu
巨头
Merck company
Mòkè gōngsī
默克公司
on (date marker)
March 25th
sānyuè èrshíwǔ rì
三月二十五日
announced
xuānbù
宣布
will / is to
jiāng
at / for (price)
approximately
yuē
$6.7 billion
67 yì měiyuán
67亿美元
to acquire
shōugòu
收购
Terns Pharmaceuticals (biotech company)
Terns Pharmaceuticals
Terns Pharmaceuticals
this / the current
cǐ cì
此次
acquisition
shōugòu
收购
at
per share
měi gǔ
每股
$53 per share
53 měiyuán
53美元
structural particle
de
price
jiàgé
价格
to proceed / to be conducted
jìnxíng
进行
compared to
jiào
recent / near-term
jìnqī
近期
share price
gǔjià
股价
at a premium
yìjià
溢价
approximately
yuē
31 percent
31%
31%
excluding / after deducting
kòuchú
扣除
the acquired party
bèi shōugòu fāng
被收购方
cash
xiànjīn
现金
assets
zīchǎn
资产
after
hòu
actual / net
shíjì
实际
net
jìng
acquisition value
shōugòu é
收购额
approximately
yuē
is
wéi
$5.7 billion
57 yì měiyuán
57亿美元
deal / transaction
jiāoyì
交易
structural particle
de
core / central
héxīn
核心
asset
zīchǎn
资产
is
shì
Terns
Terns
Terns
company
gōngsī
公司
developed / R&D
yánfā
研发
structural particle
de
drug candidate
hòuxuǎn yàowù
候选药物
TERN-701 (oral leukemia drug candidate)
TERN-701
TERN-701
TERN-701 (drug candidate)
TERN-701
TERN-701
is
shì
a type of
yī zhǒng
一种
oral / taken by mouth
kǒufú
口服
small molecule
xiǎo fēnzǐ
小分子
targeted / targeted therapy
bǎxiàng
靶向
drug / medication
yàowù
药物
currently in the stage of
zhèng chǔyú
正处于
treating / treatment of
zhìliáo
治疗
chronic myeloid leukemia
mànxìng lì xìbāo báixuèbìng
慢性粒细胞白血病
structural particle
de
clinical trial
línchuáng shìyàn
临床试验
stage / phase
jiēduàn
阶段
analysts
fēnxī rénshì
分析人士
to believe / to consider
rènwéi
认为
TERN-701 (drug candidate)
TERN-701
TERN-701
has the potential to / is expected to
yǒuwàng
有望
to become
chéngwéi
成为
value / market worth
shìzhí
市值
multi-billion dollars
shù shí yì měiyuán
数十亿美元
structural particle
de
blockbuster / major
zhòngpàng
重磅
product
chǎnpǐn
产品
and / also
bìng
against / toward
duì
Novartis (pharmaceutical company)
Nuòhuá
诺华
under / subsidiary brand
qí xià
旗下
structural particle
de
Scemblix (leukemia drug by Novartis)
Scemblix
Scemblix
to pose / to constitute
gòuchéng
构成
competition
jìngzhēng
竞争
this
cǐ cì
此次
acquisition
bìnggòu
并购
is
shì
Merck
Mòkè
默克
in the past year
jìn yī nián
近一年
within
nèi
completed
wánchéng
完成
structural particle
de
the third
dì sān bǐ
第三笔
major / significant
zhòngdà
重大
acquisition
shōugòu
收购
aimed at
zhǐzài
旨在
to strengthen
qiánghuà
强化
its
cancer
áizhèng
癌症
R&D / research and development
yánfā
研发
pipeline (pharmaceutical)
guǎnxiàn
管线
its
flagship / star
míngxīng
明星
drug
yàowù
药物
Keytruda (cancer immunotherapy drug)
Keytruda
Keytruda
structural particle
de
patent
zhuānlì
专利
will
jiāng
in
the year 2028
2028 nián
2028年
expire / expiry
dàoqī
到期

New Words

zhìyào
制药
pharmaceutical
shōugòu
收购
to acquire
měi gǔ
每股
per share
yìjià
溢价
at a premium
hòuxuǎn yàowù
候选药物
drug candidate
kǒufú
口服
oral
bǎxiàng
靶向
targeted
línchuáng shìyàn
临床试验
clinical trial
guǎnxiàn
管线
pipeline
zhuānlì
专利
patent

News in English

Business

Merck to Acquire Terns Pharmaceuticals for $6.7 Billion

Merck announced a deal worth roughly $6.7 billion to acquire Terns Pharmaceuticals and its leukemia drug candidate TERN-701. The deal is aimed at strengthening Merck cancer pipeline ahead of the patent expiry of flagship drug Keytruda in 2028.

American pharmaceutical giant Merck announced on March 25 that it will acquire Terns Pharmaceuticals for approximately $6.7 billion.

This acquisition is being conducted at $53 per share, representing a premium of approximately 31 percent over recent share prices.

After deducting the acquired company's cash assets, the actual net acquisition value is approximately $5.7 billion.

The core asset of this transaction is Terns' drug candidate TERN-701.

TERN-701 is an oral small molecule targeted drug currently in clinical trial stages for treating chronic myeloid leukemia.

Analysts believe TERN-701 has the potential to become a multi-billion dollar blockbuster product and poses competition to Novartis' Scemblix leukemia drug.

This acquisition is Merck's third major acquisition completed within the past year, aimed at strengthening its cancer research and development pipeline.

Its flagship drug Keytruda's patent will expire in 2028.

More in Business

Momenta
Móméng tǎ
摩蒙塔
Hong Kong
Xiānggǎng
香港
listed
shàngshì
上市
fundraising
róngjī
融资
$752 million
7.52 yì měiyuán
7.52亿美元

Chinese Autonomous Driving Firm Momenta Debuts on Hong Kong Stock Exchange with 752 Million Fundraise

Samsung (South Korean electronics company)
Sānxīng
三星
SK Hynix (South Korean memory chipmaker)
SK Hǎilìshì
SK海力士
and / together with
Micron (US semiconductor company)
Měiguāng
美光
to race to / to vie in
jìngxiāng
竞相
to expand / to increase
kuòdà
扩大
AI / artificial intelligence
AI
AI
memory (computing)
nèicún
内存
chip / semiconductor chip
xīnpiàn
芯片
production capacity
chǎnnéng
产能

Samsung, SK Hynix and Micron Race to Expand AI Memory Chip Capacity

China
Zhōngguó
中国
artificial intelligence
réngōng zhìnéng
人工智能
company
gōngsī
公司
MiniMax (Chinese AI company)
MiniMax
MiniMax
to complete
wánchéng
完成
$2 billion
èrshí yì měiyuán
二十亿美元
fundraising / financing
róngzī
融资

Chinese AI Firm MiniMax Raises 2 Billion Dollars in Hong Kong Share Sale

PepsiCo
Bǎishì Gōngsī
百事公司
earnings / performance
yèjī
业绩
lower than / below
dīyú
低于
expectation / forecast
yùqī
预期
the United States
Měiguó
美国
stock market
gǔshì
股市
slightly / marginally
xiǎofú
小幅
to rise / to increase
shàngzhǎng
上涨

PepsiCo Earnings Disappoint as US Stocks Edge Higher